Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Law

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Oncotarget|October 30, 2016
Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinomaAnnie Wai Yeeng Chai, Arthur Kwok Leung Cheung, Wei Dai, et al.
Theranostics|May 1, 2019
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical SignificanceBin Li, Pan Hong, Can-Can Zheng, et al.
Trials|June 22, 2021
Methods for conducting international Delphi surveys to optimise global participation in core outcome set development: a case study in gastric cancer informed by a comprehensive literature reviewBilal Alkhaffaf, Jane M Blazeby, Aleksandra Metryka, et al.
Nature Genetics|November 1, 2011
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancerKai Wang, Junsuo Kan, Siu Tsan Yuen, et al.
The Lancet. Gastroenterology & Hepatology|November 30, 2020
Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trialHan Kwang Yang, Jiafu Ji, Sang Uk Han, et al.
BMC Cancer|March 8, 2020
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort studyXiaobin Zhang, Ben M Eyck, Yang Yang, et al.
British Journal of Cancer|August 8, 2025
Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinomaJosephine Mun-Yee Ko, Chen Guo, Alvin Ka-Kiu Leung, et al.
Annals of Surgery|December 24, 2016
Esophageal Cancer: Associations With (pN+) Lymph Node MetastasesThomas W Rice, Hemant Ishwaran, Wayne L Hofstetter, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 29, 2025
NAT10 Increases Lysosomal Acidification to Promote Esophageal Cancer Metastasis via ac4C Acetylation of ATP6V0E1 mRNAYu-Juan Zhan, Chun-Miao Deng, Lin Tang, et al.
Annals of Surgery|December 6, 2017
Benchmarking Complications Associated with EsophagectomyDonald E Low, Madhan Kumar Kuppusamy, Derek Alderson, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Oncotarget|October 30, 2016
Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinomaAnnie Wai Yeeng Chai, Arthur Kwok Leung Cheung, Wei Dai, et al.
Theranostics|May 1, 2019
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical SignificanceBin Li, Pan Hong, Can-Can Zheng, et al.
Trials|June 22, 2021
Methods for conducting international Delphi surveys to optimise global participation in core outcome set development: a case study in gastric cancer informed by a comprehensive literature reviewBilal Alkhaffaf, Jane M Blazeby, Aleksandra Metryka, et al.
Nature Genetics|November 1, 2011
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancerKai Wang, Junsuo Kan, Siu Tsan Yuen, et al.
The Lancet. Gastroenterology & Hepatology|November 30, 2020
Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trialHan Kwang Yang, Jiafu Ji, Sang Uk Han, et al.
BMC Cancer|March 8, 2020
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort studyXiaobin Zhang, Ben M Eyck, Yang Yang, et al.
British Journal of Cancer|August 8, 2025
Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinomaJosephine Mun-Yee Ko, Chen Guo, Alvin Ka-Kiu Leung, et al.
Annals of Surgery|December 24, 2016
Esophageal Cancer: Associations With (pN+) Lymph Node MetastasesThomas W Rice, Hemant Ishwaran, Wayne L Hofstetter, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 29, 2025
NAT10 Increases Lysosomal Acidification to Promote Esophageal Cancer Metastasis via ac4C Acetylation of ATP6V0E1 mRNAYu-Juan Zhan, Chun-Miao Deng, Lin Tang, et al.
Annals of Surgery|December 6, 2017
Benchmarking Complications Associated with EsophagectomyDonald E Low, Madhan Kumar Kuppusamy, Derek Alderson, et al.
Pageof 21